Enzyme binary complex

This means that this dehydrogenase can form binary complexes with steroid substrates, binary complexes with pyridine nucleotide, and ternary complexes with both substrates. This behavior contrasts with that usually observed for NAD-linked dehydrogenases in which the ketone or aldehyde substrate can bind only to the NADH-enzyme binary complex but not to free enzyme (29). 

Compared with the Mn -enzyme binary complex, the ternary complex (en-zyme-Mn -pdTp) has one more water molecule in the second coordination sphere of the metal ion (20). The additional water molecule apparently replaces the Glu-43 carboxylate which is coordinated with the metal ion in the binary complex. This and other evidence suggests that, in the ternary complex, the side chain carboxylate of Glu-43 acts as a general base potentiating the attack of the water molecule on the phosphodiester bond. The guanidinium ion of Arg-87 is also appropriately positioned to both bind and catalytically activate the 5 -phosphate group of the substrate. Since all five Arg residues in the protein have pK values greater than 11.6, Arg-87 may be a candidate for the acidic catalyst that protonates the 5 -ribose alkoxide prior to product release (17). 

In this type of sequential reaction, all possible binary enzyme substrate complexes (AE, EB, QE, EP) are formed rapidly and reversibly when the enzyme is added to a reaction mixture containing A, B, P, and Q ... 

Plasminogen activator inhibitors have been shown to be present in a large variety of different cells and tissues. These inhibitors are thought to play an important role in regulating tissue fibrinolysis. One of these inhibitors has been purified from cultured bovine aortic epithelial cells. This inhibitor has been shown to be a serine protease inhibitor and inhibits the function of two proteolytic enzymes urokinase and tissue plasminogen activator, both of which cleave and activate plasminogen. The mechanism by which this inhibitor functions is very similar to that described above with a-l-PI. Thus, the inhibitor forms a binary complex with the proteolytic enzyme and thereby inhibits its activity. Again in a situation comparable to that with a-l-PI, it was found that when the purified bovine aortic epithelial inhibitor was exposed to Al-chlorosuccinimide,... 

The binary complex ES is commonly referred to as the ES complex, the initial encounter complex, or the Michaelis complex. As described above, formation of the ES complex represents a thermodynamic equilibrium, and is hence quantifiable in terms of an equilibrium dissociation constant, Kd, or in the specific case of an enzyme-substrate complex, Ks, which is defined as the ratio of reactant and product concentrations, and also by the ratio of the rate constants kM and km (see Appendix 2) ... 

As we have just seen, the initial encounter complex between an enzyme and its substrate is characterized by a reversible equilibrium between the binary complex and the free forms of enzyme and substrate. Hence the binary complex is stabilized through a variety of noncovalent interactions between the substrate and enzyme molecules. Likewise the majority of pharmacologically relevant enzyme inhibitors, which we will encounter in subsequent chapters, bind to their enzyme targets through a combination of noncovalent interactions. Some of the more important of these noncovalent forces for interactions between proteins (e.g., enzymes) and ligands (e.g., substrates, cofactors, and reversible inhibitors) include electrostatic interactions, hydrogen bonds, hydrophobic forces, and van der Waals forces (Copeland, 2000). 

Miller and Wolfenden, 2002). This latter ratio is the inverse of the rate enhancement achieved by the enzyme. In other words, the enzyme active site will have greater affinity for the transition state structure than for the ground state substrate structure, by an amount equivalent to the fold rate enhancement of the enzyme (rearranging, we can calculate KJX = Ksik Jk, )). Table 2.2 provides some examples of enzymatic rate enhancements and the calculated values of the dissociation constant for the /A binary complex (Wolfenden, 1999). 

A second ternary complex reaction mechanism is one in which there is a compulsory order to the substrate binding sequence. Reactions that conform to this mechanism are referred to as bi-bi compulsory ordered ternary complex reactions (Figure 2.13). In this type of mechanism, productive catalysis only occurs when the second substrate binds subsequent to the first substrate. In many cases, the second substrate has very low affinity for the free enzyme, and significantly greater affinity for the binary complex between the enzyme and the first substrate. Thus, for all practical purposes, the second substrate cannot bind to the enzyme unless the first substrate is already bound. In other cases, the second substrate can bind to the free enzyme, but this binding event leads to a nonproductive binary complex that does not participate in catalysis. The formation of such a nonproductive binary complex would deplete the population of free enzyme available to participate in catalysis, and would thus be inhibitory (one example of a phenomenon known as substrate inhibition see Copeland, 2000, for further details). When substrate-inhibition is not significant, the overall steady state velocity equation for a mechanism of this type, in which AX binds prior to B, is given by Equation (2.16) ... 

In this chapter we have seen that enzymatic catalysis is initiated by the reversible interactions of a substrate molecule with the active site of the enzyme to form a non-covalent binary complex. The chemical transformation of the substrate to the product molecule occurs within the context of the enzyme active site subsequent to initial complex formation. We saw that the enormous rate enhancements for enzyme-catalyzed reactions are the result of specific mechanisms that enzymes use to achieve large reductions in the energy of activation associated with attainment of the reaction transition state structure. Stabilization of the reaction transition state in the context of the enzymatic reaction is the key contributor to both enzymatic rate enhancement and substrate specificity. We described several chemical strategies by which enzymes achieve this transition state stabilization. We also saw in this chapter that enzyme reactions are most commonly studied by following the kinetics of these reactions under steady state conditions. We defined three kinetic constants—kai KM, and kcJKM—that can be used to define the efficiency of enzymatic catalysis, and each reports on different portions of the enzymatic reaction pathway. Perturbations... 

We have already used the interactions of methotrexate with dihydrofolate reductase (DHFR) several times within this text to illustrate some key aspects of enzyme inhibition. The reader will recall that methotrexate binds to both the free enzyme and the enzyme-NADPH binary complex but displays much greater affinity for the latter species. The time dependence of methotrexate binding to bacterial DHFR was studied by Williams et al. (1979) under conditions of saturating [NADPH], In the presence of varying concentrations of methotrexate, the progress curves for DHFR activity became progressively more nonlinear (Figure 6.14). The value of kobs from... 

Figure 6.17 Cartoon depicting the interactions of FKBP with inhibitor and the subsequent binding of the FKBP Inhibitor binary complex to the enzyme calcineurin (E).

Often high-affinity, or tight binding, interactions with enzymes is the result of a very slow dissociation rate of the enzyme-inhibitor binary complex. 

Let us assume that for a particular enzyme-inhibitor pair, association is diffusion limited so that k, is I O9 M s1. Fixing k n at this value, and using Equation (7.26), we can determine the value of koB for different values of Kn as summarized in Table 7.3 (this is taken from the more comprehensive table presented in Chapter 2). We have already seen examples in Chapter 6 of compounds with A) values (or Kf values) in the lOnM to lOpM range for which the half-life for binary complex dissociation is far longer than 2 hours. For example, we saw that inhibition of COX2 by DuP697 resulted in a final E I complex with Kf = 5 nM and the lm for complex... 

Table 7.3 Values of k for different values for enzyme-inhibitor binary complexes when the rate of complex association is diffusion-limited (k = I09M W)...

Until now our discussions of enzyme inhibition have dealt with compounds that interact with binding pockets on the enzyme molecule through reversible forces. Hence inhibition by these compounds is always reversed by dissociation of the inhibitor from the binary enzyme-inhibitor complex. Even for very tight binding inhibitors, the interactions that stabilize the enzyme-inhibitor complex are mediated by reversible forces, and therefore the El complex has some, nonzero rate of dissociation—even if this rate is too slow to be experimentally measured. In this chapter we turn our attention to compounds that interact with an enzyme molecule in such a way as to permanendy ablate enzyme function. We refer to such compounds as enzyme inactivators to stress the mechanistic distinctions between these molecules and reversible enzyme inhibitors. 

As an illustration of first-order kinetics, let us consider the simple dissociation of a binary enzyme-inhibitor complex ( 7) to the free enzyme (E) and the free inhibitor (/),... 

Let us now consider the the reverse of the binary complex dissociation reaction that we just described. We now turn our attention to the kinetics of association between an enzyme molecule and a ligand. The association reaction is described as follows ... 

The following mechanism relates to an enzyme E with two binding sites for the substrate S. Two complexes are formed a reactive binary complex ES, and a nonreactive ternary complex ESS. ... 

The inhibition process in general may be represented by the following six-step scheme (a similar scheme may be used for activation-see problem 10-12), in which I is the inhibitor, El is a binary enzyme-inhibitor complex, and EIS is a ternary enzyme-inhibitor-substrate complex. 

---